emerging pharmaceutical markets News
Most Popular emerging pharmaceutical markets Story
AZ chief: Emerging markets are tougher than you think
AstraZeneca ($AZN) CEO David Brennan (photo) talks emerging markets, external collaborations and townhall meetings in a Q&A with Roger Crockett. And, extending the current prefence for bolt-on Read more...
Latest Headlines
- January 19, 2012
- January 17, 2012
- January 12, 2012
- December 23, 2011
- December 8, 2011
- December 6, 2011
- November 1, 2011
- October 31, 2011
- October 10, 2011
- October 6, 2011
- October 4, 2011
- September 19, 2011
- September 2, 2011
- August 29, 2011
- August 26, 2011
- August 26, 2011
- August 24, 2011
- August 23, 2011
- August 18, 2011
- August 17, 2011
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
